1942 Results

People

  1. Kattan
    Kattan
  2. Cordon-Cardo
    Cordon-Cardo
  3. Brennan
    Brennan
  4. Bornmann
    Bornmann
  5. Fong
    Fong
  6. Antonescu
    Antonescu
  7. Hudis
    Hudis
  8. Ladanyi
    Ladanyi
  9. Larson
    Larson
  10. Scher
    Scher

Groups

  1. Department of Medicine (530)
  2. Sloan Kettering Institute Faculty (484)
  3. GSK Faculty (459)
  4. Surgery (454)
  5. Molecular Pharmacology and Chemistry Program Faculty (302)
  6. Solid Tumor Oncology Division (245)
  7. Survivorship Research (229)
  8. Center for Hematologic Malignancies (173)
  9. Department of Pathology and Laboratory Medicine (168)
  10. Tow Center for Developmental Oncology (TCDO) (158)
  1. "2003"
Formats
  1. Journal Article (1307)
  2. Meeting Abstract (493)
  3. Book Section (121)
  4. Conference Paper (13)
  5. Book Whole (8)
Groups
  1. Department of Medicine (530)
  2. Sloan Kettering Institute Faculty (484)
  3. GSK Faculty (459)
  4. Surgery (454)
  5. Molecular Pharmacology and Chemistry Program Faculty (302)
  6. Solid Tumor Oncology Division (245)

More Groups

People
  1. Steven Larson (53)
  2. Michael Kattan (52)
  3. Carlos Cordon-Cardo (38)
  4. Murray Brennan (37)
  5. Peter Scardino (35)
  6. David Klimstra (34)

More People

Years
  1. 2003 (1942)
Publications
  1. Blood (97)
  2. Journal of Clinical Oncology (64)
  3. Journal of Nuclear Medicine (53)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (53)
  5. Modern Pathology (47)
  6. Laboratory Investigation (44)

More Publications

Publishers
  1. Elsevier Inc. (182)
  2. American Association for Cancer Research (137)
  3. Elsevier Science, Inc. (126)
  4. Lippincott Williams & Wilkins (117)
  5. Nature Publishing Group (113)
  6. Springer (98)

More Publishers

Results (1942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Data management and analysis of serum peptide profiling studies
    Meeting Abstract

    Philip, J.; Villanueva, J.; Tempst, P.
    Molecular & Cellular Proteomics (2003)

    Fulltext@MSK | Save
  • Stromal feeder - mediated dopaminergic differentiation of human ES cells
    Meeting Abstract

    Perrier, A. L.; Greenberg, E. D.; Tabar, V.; Studer, L.
    Society for Neuroscience Abstract Viewer and Itinerary Planner (2003)

    Fulltext@MSK | Save
  • Molecular adjuvants for cancer vaccines: From bench to bedside, with a stop in the kennel
    Meeting Abstract

    Perales, M. A.; Bergman, P. J.; Houghton, A. N.; Wolchok, J. D.
    European Cytokine Network (2003)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib (TarcevaTM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: Interim results of a phase II trial
    Meeting Abstract

    Patel, J.; Miller, V.; Kris, M.; Shah, N.; Tyson, L.; Pizzo, B.; Zakowski, M.; Cespon, M.; Heelan, R.; Johnson, D.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Isolation and characterization of four new exon 5 splice variants from the mouse mu opioid receptor gene, oprm
    Meeting Abstract

    Pan, Y. X.; Xu, J.; Bolan, E.; Moskowitz, H.; Zhang, Y.; Mahurter, L.; Xu, M.; Pasternak, G. W.
    Society for Neuroscience Abstract Viewer and Itinerary Planner (2003)

    Fulltext@MSK | Save
  • Identification and characterization of four new alternatively spliced variants from the rat mu opioid receptor gene, oprm
    Meeting Abstract

    Pan, L.; Pasternak, D. A.; Xu, J.; Xu, M.; Pan, Y. X.; Pasternak, G. W.
    Society for Neuroscience Abstract Viewer and Itinerary Planner (2003)

    Fulltext@MSK | Save
  • Phase II clinical experience with the novel proteasome inhibitor bortezomib (formerly PS-341) in patients with indolent and mantle cell lymphomas
    Meeting Abstract

    O'Connor, O. A.; Wright, J.; Moskowitz, C.; Straus, D.; Macgregor-Cortelli, B.; Muzzy, J.; Choi, P.; Schenkein, D.; Zelenetz, A. D.
    EJC Supplements (2003)

    Fulltext@MSK | Save
  • Transcriptional up-regulation of pre-m-RNA splicing factor Srp20: A novel mechanism of flavopiridol induced apoptosis in human colon cancer cells
    Meeting Abstract

    Motwani, M. V.; Cheema, H. S.; Sridhar, P.; Sirotnak, F. M.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Phosphorylated/activated HER2 (P-HER2) as a marker of clinical resistance to single agent taxane chemotherapy for meta-static breast cancer (MBC)
    Meeting Abstract

    Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save